HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Item
http://www.wikidata.org/entity/Q33755226
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantationIdentification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I moleculePrediction of T-cell epitopes of hepatitis C virus genotype 5aHLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgeniPhenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpesGeneration of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against OculDiscovering protective CD8 T cell epitopes--no single immunologic property predicts it!Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceA distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells.In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus.Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis.
P2860

HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Item
http://www.wikidata.org/entity/Q33755226
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@ast
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@en
type
label
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@ast
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@en
prefLabel
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@ast
HLA-A*01:03, HLA-A*24:02, HLA- ...... els of human T cell responses.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
HLA-A*01:03, HLA-A*24:02, HLA- ...... dels of human T cell responses
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932